ACP-105
A partial androgen receptor agonist from a tricyclic scaffold, studied for dissociated tissue effects.
SpecificationSelective Androgen Receptor Modulators
Selective androgen receptor modulators bind the androgen receptor as non-steroidal ligands and recruit co-regulator complexes that differ from those recruited by testosterone or dihydrotestosterone. That difference in co-regulator recruitment — not any difference in binding site — is what produces the tissue-selective profiles reported in animal work.
| Compound | CAS | Molecular weight | Primary target |
|---|---|---|---|
| ACP-105 | 899821-23-9 | Refer to CoA | Androgen receptor (partial agonist) |
| LGD-3303 | 917891-35-1 | Refer to CoA | Androgen receptor (full agonist, tissue-selective) |
| AC-262536 | 870888-46-3 | Refer to CoA | Androgen receptor (partial agonist) |
| RAD-150 | Refer to CoA | Refer to CoA | Androgen receptor |
Catalogue
A partial androgen receptor agonist from a tricyclic scaffold, studied for dissociated tissue effects.
SpecificationA quinolinone-derived androgen receptor agonist characterised in bone and muscle preclinical models.
SpecificationAC-262,536, Accadine
A partial androgen receptor agonist investigated in preclinical models of muscle and central androgen signalling.
SpecificationTLB-150 Benzoate
An ester derivative of the RAD-140 scaffold, developed to alter release and metabolic profile.
SpecificationNext step
Send the compound name, quantity and intended laboratory application and we will return the current specification with the analytical documentation available.